Prognostic role of plasma level of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor in hepatocellular carcinoma
Most hepatocellular carcinomas (HCCs) are hypervascular, with characteristic features of hepatic arterial supply to the tumor. The factors involved in tumor angiogenesis include angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and vascular endothelial growth factor (VEGF). To investigate the profiles...
Uloženo v:
| Vydáno v: | World journal of gastroenterology : WJG Ročník 27; číslo 27; s. 4453 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
21.07.2021
|
| Témata: | |
| ISSN: | 2219-2840, 2219-2840 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Most hepatocellular carcinomas (HCCs) are hypervascular, with characteristic features of hepatic arterial supply to the tumor. The factors involved in tumor angiogenesis include angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and vascular endothelial growth factor (VEGF).
To investigate the profiles of plasma levels of angiogenesis markers in patients with HCC and evaluate their roles in predicting overall survival (OS) and progression-free survival (PFS).
Plasma samples from 240 prospectively enrolled HCC patients in the very early to advanced stages were used to measure the levels of Ang-1, Ang-2, and VEGF. Their associations with clinical characteristics, OS, and PFS were analyzed.
The median plasma levels of Ang-1, Ang-2, and VEGF were 3216 pg/mL, 1684 pg/mL, and 26.5 pg/mL, respectively. The plasma level of Ang-2 showed a significant increase from early stage [Barcelona clinic liver cancer (BCLC) A] to intermediate (BCLC B) and advanced stage HCC (BCLC C/D), whereas Ang-1, VEGF, and alpha-fetoprotein (AFP) levels in the plasma did not show any such changes. Multivariable analysis, propensity score-matched analysis, and time-dependent receiver operating curve analysis revealed that Ang-2 levels had the highest predictive power for OS and PFS. Neither Ang-1 nor VEGF was significantly associated with OS or PFS. The neutrophil-to-lymphocyte ratio was an independent factor for OS and PFS.
The plasma levels of Ang-2 correlated with liver function, tumor stage, and tumor invasiveness, showing better performance in predicting OS and PFS than AFP, Ang-1, or VEGF. |
|---|---|
| AbstractList | Most hepatocellular carcinomas (HCCs) are hypervascular, with characteristic features of hepatic arterial supply to the tumor. The factors involved in tumor angiogenesis include angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and vascular endothelial growth factor (VEGF).BACKGROUNDMost hepatocellular carcinomas (HCCs) are hypervascular, with characteristic features of hepatic arterial supply to the tumor. The factors involved in tumor angiogenesis include angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and vascular endothelial growth factor (VEGF).To investigate the profiles of plasma levels of angiogenesis markers in patients with HCC and evaluate their roles in predicting overall survival (OS) and progression-free survival (PFS).AIMTo investigate the profiles of plasma levels of angiogenesis markers in patients with HCC and evaluate their roles in predicting overall survival (OS) and progression-free survival (PFS).Plasma samples from 240 prospectively enrolled HCC patients in the very early to advanced stages were used to measure the levels of Ang-1, Ang-2, and VEGF. Their associations with clinical characteristics, OS, and PFS were analyzed.METHODSPlasma samples from 240 prospectively enrolled HCC patients in the very early to advanced stages were used to measure the levels of Ang-1, Ang-2, and VEGF. Their associations with clinical characteristics, OS, and PFS were analyzed.The median plasma levels of Ang-1, Ang-2, and VEGF were 3216 pg/mL, 1684 pg/mL, and 26.5 pg/mL, respectively. The plasma level of Ang-2 showed a significant increase from early stage [Barcelona clinic liver cancer (BCLC) A] to intermediate (BCLC B) and advanced stage HCC (BCLC C/D), whereas Ang-1, VEGF, and alpha-fetoprotein (AFP) levels in the plasma did not show any such changes. Multivariable analysis, propensity score-matched analysis, and time-dependent receiver operating curve analysis revealed that Ang-2 levels had the highest predictive power for OS and PFS. Neither Ang-1 nor VEGF was significantly associated with OS or PFS. The neutrophil-to-lymphocyte ratio was an independent factor for OS and PFS.RESULTSThe median plasma levels of Ang-1, Ang-2, and VEGF were 3216 pg/mL, 1684 pg/mL, and 26.5 pg/mL, respectively. The plasma level of Ang-2 showed a significant increase from early stage [Barcelona clinic liver cancer (BCLC) A] to intermediate (BCLC B) and advanced stage HCC (BCLC C/D), whereas Ang-1, VEGF, and alpha-fetoprotein (AFP) levels in the plasma did not show any such changes. Multivariable analysis, propensity score-matched analysis, and time-dependent receiver operating curve analysis revealed that Ang-2 levels had the highest predictive power for OS and PFS. Neither Ang-1 nor VEGF was significantly associated with OS or PFS. The neutrophil-to-lymphocyte ratio was an independent factor for OS and PFS.The plasma levels of Ang-2 correlated with liver function, tumor stage, and tumor invasiveness, showing better performance in predicting OS and PFS than AFP, Ang-1, or VEGF.CONCLUSIONThe plasma levels of Ang-2 correlated with liver function, tumor stage, and tumor invasiveness, showing better performance in predicting OS and PFS than AFP, Ang-1, or VEGF. Most hepatocellular carcinomas (HCCs) are hypervascular, with characteristic features of hepatic arterial supply to the tumor. The factors involved in tumor angiogenesis include angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and vascular endothelial growth factor (VEGF). To investigate the profiles of plasma levels of angiogenesis markers in patients with HCC and evaluate their roles in predicting overall survival (OS) and progression-free survival (PFS). Plasma samples from 240 prospectively enrolled HCC patients in the very early to advanced stages were used to measure the levels of Ang-1, Ang-2, and VEGF. Their associations with clinical characteristics, OS, and PFS were analyzed. The median plasma levels of Ang-1, Ang-2, and VEGF were 3216 pg/mL, 1684 pg/mL, and 26.5 pg/mL, respectively. The plasma level of Ang-2 showed a significant increase from early stage [Barcelona clinic liver cancer (BCLC) A] to intermediate (BCLC B) and advanced stage HCC (BCLC C/D), whereas Ang-1, VEGF, and alpha-fetoprotein (AFP) levels in the plasma did not show any such changes. Multivariable analysis, propensity score-matched analysis, and time-dependent receiver operating curve analysis revealed that Ang-2 levels had the highest predictive power for OS and PFS. Neither Ang-1 nor VEGF was significantly associated with OS or PFS. The neutrophil-to-lymphocyte ratio was an independent factor for OS and PFS. The plasma levels of Ang-2 correlated with liver function, tumor stage, and tumor invasiveness, showing better performance in predicting OS and PFS than AFP, Ang-1, or VEGF. |
| Author | Choi, Gwang Hyeon Jang, Eun Sun Jeong, Sook-Hyang Kim, Jin-Wook |
| Author_xml | – sequence: 1 givenname: Gwang Hyeon surname: Choi fullname: Choi, Gwang Hyeon organization: Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, South Korea – sequence: 2 givenname: Eun Sun surname: Jang fullname: Jang, Eun Sun organization: Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, South Korea – sequence: 3 givenname: Jin-Wook surname: Kim fullname: Kim, Jin-Wook organization: Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, South Korea – sequence: 4 givenname: Sook-Hyang surname: Jeong fullname: Jeong, Sook-Hyang email: jsh@snubh.org organization: Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, South Korea. jsh@snubh.org |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34366616$$D View this record in MEDLINE/PubMed |
| BookMark | eNpVkE1PwzAMhiM0xD7gzgnlyIGOJk3b7IgmviQkOMC5clO3y5QmJWk38QP432wwJDhY9iM9tqx3SkbWWSTknMXzJBfyertu5huez_WuhEiTIzLhnC0iLkU8-jOPyTSEdRzzJEn5CRknIsmyjGUT8vniXWNd6LWi3hmkrqadgdACNbhBs2ewjXad09hrG7Gr_8z3XNENBDUY8BRt5foVGg2GNt5t-xWtQfXOU23pCjvonUJjvl0FXmnrWjglxzWYgGeHPiNvd7evy4fo6fn-cXnzFCmR8T6CtIQ0SxVCWSpWyzqXTC0gZ6qucyaUYiDzLE9UmWYCJQoZ40JVEOeYVCKWfEYuf-523r0PGPqi1WH_Dlh0Qyh4mi52-1KInXpxUIeyxarovG7BfxS_0fEvo3N2VA |
| CitedBy_id | crossref_primary_10_1186_s10020_025_01194_6 crossref_primary_10_12677_acm_2025_1582301 crossref_primary_10_3389_fphar_2024_1440985 crossref_primary_10_3390_cancers14194647 crossref_primary_10_3390_ijms23031636 crossref_primary_10_1007_s00261_023_04007_8 crossref_primary_10_3748_wjg_v28_i30_4221 crossref_primary_10_1007_s12094_023_03084_x crossref_primary_10_12688_f1000research_145606_1 crossref_primary_10_1016_j_nutres_2024_06_010 crossref_primary_10_3390_biology10111212 crossref_primary_10_3390_metabo15020091 crossref_primary_10_3389_fimmu_2022_1033967 crossref_primary_10_3390_cancers17162642 crossref_primary_10_4254_wjh_v16_i12_1371 crossref_primary_10_3389_fimmu_2024_1489077 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Copyright_xml | – notice: The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.3748/wjg.v27.i27.4453 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| EISSN | 2219-2840 |
| ExternalDocumentID | 34366616 |
| Genre | Journal Article |
| GroupedDBID | --- 123 29R 2WC 36B 53G 5VR 8WL AAKDD ACGFO AENEX ALMA_UNASSIGNED_HOLDINGS CCEZO CGR CHBEP CIEJG CS3 CUY CVF CW9 DIK DU5 E3Z EBS ECM EIF EJD F5P FA0 FRP GX1 HYE NPM OK1 P2P RNS RPM TR2 XSB 7X8 |
| ID | FETCH-LOGICAL-c462t-a5ba565ceabbc1f8f781c9a71cff714cc1a87673cb564e8e480e9cda07e3d4082 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 16 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000679322100013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2219-2840 |
| IngestDate | Thu Jul 10 23:11:03 EDT 2025 Thu Apr 03 07:07:25 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 27 |
| Keywords | Angiogenesis Hepatocellular carcinoma Biomarker Prognosis Survival |
| Language | English |
| License | The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c462t-a5ba565ceabbc1f8f781c9a71cff714cc1a87673cb564e8e480e9cda07e3d4082 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/8316901 |
| PMID | 34366616 |
| PQID | 2559673844 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2559673844 pubmed_primary_34366616 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-Jul-21 20210721 |
| PublicationDateYYYYMMDD | 2021-07-21 |
| PublicationDate_xml | – month: 07 year: 2021 text: 2021-Jul-21 day: 21 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | World journal of gastroenterology : WJG |
| PublicationTitleAlternate | World J Gastroenterol |
| PublicationYear | 2021 |
| SSID | ssj0023352 |
| Score | 2.4344068 |
| Snippet | Most hepatocellular carcinomas (HCCs) are hypervascular, with characteristic features of hepatic arterial supply to the tumor. The factors involved in tumor... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 4453 |
| SubjectTerms | Angiopoietin-1 Angiopoietin-2 Carcinoma, Hepatocellular - blood Carcinoma, Hepatocellular - blood supply Humans Liver Neoplasms Neovascularization, Pathologic Prognosis Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors |
| Title | Prognostic role of plasma level of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor in hepatocellular carcinoma |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34366616 https://www.proquest.com/docview/2559673844 |
| Volume | 27 |
| WOSCitedRecordID | wos000679322100013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8QwFA5uBy8uuG9E8GhmmjZt0pOIOHjQYQ4qcxvSNJmpaDM6o_4C_7fvtR3FgyB4aOGVFELytuQtHyEnKrbSRloxkxvFhOYgUjpJmXQmclGahbLqs31_Lbtd1e-nvebCbdKkVc50YqWoc2_wjryNri8iVApxNn5miBqF0dUGQmOeLEbgyiBXy_5XFCHEeiIElwOpZKCGgzpMiQ1X2u8Pw9ZbKFsFPEIgNPJvDmZlaDqr_53iGllpXEx6XvPEOpmz5Qb56L14zKmDbxQzCql3dAye85Omj5g3hLQuh4Uf-wKroBk__UmHSOd0lrlKbZlj8dYj8C8dwll-OqI1dg8tSjoCIzf1GBSoxhoELCr9k94kd53L24sr1kAwMCOScMp0nGlw-YzVWWa4U04qblItuXFOcmEM16BOZWSyOBFWWaECm5pcB8AAOWJZb5GF0pd2h1CTZTCMp3mkEhFXZjEJg1zKOHVSi2SXHM9WdQAsjlPUpfWvk8H3uu6S7XprBuO6F8cgEhEcwHiy94e_98lyiBkpgWQhPyCLDgTcHpIl8zYtJi9HFe_Au9u7-QT22dHw |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+role+of+plasma+level+of+angiopoietin-1%2C+angiopoietin-2%2C+and+vascular+endothelial+growth+factor+in+hepatocellular+carcinoma&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Choi%2C+Gwang+Hyeon&rft.au=Jang%2C+Eun+Sun&rft.au=Kim%2C+Jin-Wook&rft.au=Jeong%2C+Sook-Hyang&rft.date=2021-07-21&rft.eissn=2219-2840&rft.volume=27&rft.issue=27&rft.spage=4453&rft_id=info:doi/10.3748%2Fwjg.v27.i27.4453&rft_id=info%3Apmid%2F34366616&rft_id=info%3Apmid%2F34366616&rft.externalDocID=34366616 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2219-2840&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2219-2840&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2219-2840&client=summon |